| MEDICAB Stock | | | MXN 32.61 0.60 1.87% |
Director
Mr. Enrique Castillo Sanchez Mejorada serves as Independent Director of Medica Sur, S.A.B. de C.V. since April 2011. He served as Member of the Companys Audit Committee until April 24, 2012. He acts as General Manager of Retail Banking of Grupo Financiero Banorte. Before that, he served as Chairman of the Board of Directors and Executive President of Ixe Grupo Financiero SAB de CV. Between 2007 and 2009, He acted as President of la Asociacion de Bancos de Mexico. In addition, he serves as Independent Member of the Board of Directors of Grupo Herdez SAB de CV, Alfa SAB de CV, Grupo Embotelladoras Unidas SAB de CV, Grupo Casa Saba SAB de CV, and Southern Copper Corporationrationration. He holds a Bachelors degree in Business Administration from Universidad Anahuac. since 2011.
| Age | 60 |
| Tenure | 13 years |
| Phone | 52 55 4635 5600 |
| Web | https://www.medicasur.com.mx |
Mdica Sur Management Efficiency
The company has return on total asset
(ROA) of
0.0682 % which means that it generated a profit of $0.0682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1095 %, meaning that it generated $0.1095 on every $100 dollars invested by stockholders. Mdica Sur's management efficiency ratios could be used to measure how well Mdica Sur manages its routine affairs as well as how well it operates its assets and liabilities.
Mdica Sur SAB has accumulated 991.93
M in total debt with debt to equity ratio
(D/E) of 0.3, which may suggest the company is not taking enough advantage from borrowing. Mdica Sur SAB has a current ratio of 1.76, which is within standard range for the sector. Debt can assist Mdica Sur until it has trouble settling it off, either with new capital or with free cash flow. So, Mdica Sur's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mdica Sur SAB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mdica to invest in growth at high rates of return. When we think about Mdica Sur's use of debt, we should always consider it together with cash and equity.
Mdica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services. MEDICA SUR operates under Medical Care Facilities classification in Mexico and is traded on Mexico Stock Exchange. It employs 3573 people. Mdica Sur SAB (MEDICAB) is traded on Mexican Exchange in Mexico and employs 2,044 people.
Management Performance
Mdica Sur SAB Leadership Team
Elected by the shareholders, the Mdica Sur's board of directors comprises two types of representatives: Mdica Sur inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mdica. The board's role is to monitor Mdica Sur's management team and ensure that shareholders' interests are well served. Mdica Sur's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mdica Sur's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jose Rovelo, Director of Surgery, Director | |
| Engineer Nieves, Director HR | |
| Martha Ostos, Ex Imaging | |
| Jorge Reyna, Director of Systems and Information Technology | |
| Concepcion Ruiloba, Director of Marketing, Communication and Special Events | |
| Jos Ortiz, Chief Officer | |
| Francisco Jimenez, Independent Director | |
| Santiago Borde, Independent Director | |
| Fernando Navarro, Director | |
| Juan Hernando, Chief Executive Officer, Director | |
| Daniel Loaisa, Independent Director | |
| Omar Garcia, Director of Human Resources | |
| Xavier Mainero, Independent Director | |
| Luis Morales, Independent Director | |
| Ruben Cruz, Director of Internal Audit | |
| Jorge Martinez, Director of Sales | |
| Juan Ramirez, Independent Director | |
| Manuel Madrid, Independent Director | |
| Jaime Gracia, Alliances Strategy | |
| Eduardo Pier, Independent Director | |
| Misael Esquivel, Chairman of the Board, Executive President | |
| Mario Benard, Director | |
| L Hernando, MD Director | |
| Santiago Servitje, Director, Laboratory Director | |
| Alejandro Pradrazzi, Independent Director | |
| Joaquin Guajardo, Independent Director | |
| Cuauhtemoc Otero, Interim Legal Director, Secretary | |
| Marisol Mollon, Chief Financial and Administrative Officer | |
| Santiago Perez, Independent Director | |
| Octavio Chon, Medical General Director, Director and Member of Corporate Practice Committee | |
| Xochitl Castaneda, Independent Director | |
| Genaro Estrada, Director | |
| Enrique Mejorada, Independent Director | |
Mdica Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mdica Sur a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Mdica Stock
Mdica Sur financial ratios help investors to determine whether Mdica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mdica with respect to the benefits of owning Mdica Sur security.